These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26625157)

  • 21. Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients.
    Pineda JA; Cifuentes C; Parra M; Merchante N; Pérez-Navarro E; Rivero-Juárez A; Monje P; Rivero A; Macías J; Real LM
    AIDS; 2014 Aug; 28(13):1931-7. PubMed ID: 24979724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates.
    Wenzel JJ; Preiss J; Schemmerer M; Huber B; Jilg W
    J Infect Dis; 2013 Feb; 207(3):497-500. PubMed ID: 23148290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-hepatitis E virus antibody prevalence in French expatriate workers.
    Vernier M; Rossi-Tamisier M; Richet H; Brouqui P; Parola P; Bouamri Y; Colson P; Gautret P
    Int J Infect Dis; 2013 Nov; 17(11):e1082-4. PubMed ID: 23953700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of antibodies against hepatitis E virus in HIV-infected patients with unexplained liver disease.
    Merchante N; Parra-Sánchez M; Rivero-Juárez A; Cifuentes C; Camacho Á; Macías J; Martínez-Dueñas L; Pérez-Navarro E; Rivero A; Pineda JA
    Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):532-5. PubMed ID: 25533742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis E virus antibodies in HIV-infected patients and blood donors from western Poland: A preliminary report.
    Bura M; Bukowska A; Bura A; Michalak M; Mozer-Lisewska I
    Adv Clin Exp Med; 2017 Jul; 26(4):577-579. PubMed ID: 28691422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation of the hepatitis E virus seroprevalence in cases admitted to Hacettepe University Medical Faculty Hospital].
    Aydın NN; Ergünay K; Karagül A; Pınar A; Us D
    Mikrobiyol Bul; 2015 Oct; 49(4):554-64. PubMed ID: 26649413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence of hepatitis E in HIV infected patients in Greece.
    Politou M; Boti S; Androutsakos T; Valsami S; Pittaras T; Kapsimali V
    J Med Virol; 2015 Sep; 87(9):1517-20. PubMed ID: 25965115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis E seroprevalence in recipients of renal transplants or haemodialysis in southwest England: a case-control study.
    Harrison A; Scobie L; Crossan C; Parry R; Johnston P; Stratton J; Dickinson S; Ellis V; Hunter JG; Prescott OR; Madden R; Lin NX; Henley WE; Bendall RP; Dalton HR
    J Med Virol; 2013 Feb; 85(2):266-71. PubMed ID: 23169048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis E prevalence among HIV infected patients with elevated liver enzymes in the Netherlands.
    Hassing RJ; van der Eijk AA; Lopes VB; Snijdewind IJ; de Man RA; Pas SD; van der Ende ME
    J Clin Virol; 2014 Aug; 60(4):408-10. PubMed ID: 24929755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance evaluation of five commercial assays in assessing seroprevalence of HEV antibodies among blood donors.
    Al-Absi ES; Al-Sadeq DW; Younis MH; Yassine HM; Abdalla OM; Mesleh AG; Hadwan TA; Amimo JO; Thalib L; Nasrallah GK
    J Med Microbiol; 2018 Sep; 67(9):1302-1309. PubMed ID: 30051802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis E virus IgG seroprevalence in HIV patients and blood donors, west-central Poland.
    Bura M; Łagiedo M; Michalak M; Sikora J; Mozer-Lisewska I
    Int J Infect Dis; 2017 Aug; 61():20-22. PubMed ID: 28576599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of hepatitis E virus (HEV) in humans living in high pig density areas of Germany.
    Krumbholz A; Joel S; Dremsek P; Neubert A; Johne R; Dürrwald R; Walther M; Müller TH; Kühnel D; Lange J; Wutzler P; Sauerbrei A; Ulrich RG; Zell R
    Med Microbiol Immunol; 2014 Aug; 203(4):273-82. PubMed ID: 24744181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence of anti-hepatitis E antibodies and antigens among HIV-infected patients in Fars Province, southern Iran.
    Shahriarirad R; Erfani A; Rastegarian M; Zeighami A; Arefkhah N; Ghorbani F; Sarvari J; Sarkari B
    Virol J; 2020 Jul; 17(1):109. PubMed ID: 32680534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of hepatitis E virus antibodies among blood donors in Southern Brazil.
    Passos-Castilho AM; de Sena A; Geraldo A; Spada C; Granato CF
    J Med Virol; 2016 Feb; 88(2):361-4. PubMed ID: 26211918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients.
    Pas SD; Streefkerk RH; Pronk M; de Man RA; Beersma MF; Osterhaus AD; van der Eijk AA
    J Clin Virol; 2013 Dec; 58(4):629-34. PubMed ID: 24210958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of anti-HEV IgG in 182 Polish patients.
    Bura M; Michalak M; Chojnicki M; Czajka A; Kowala-Piaskowska A; Mozer-Lisewska I
    Postepy Hig Med Dosw (Online); 2015 Mar; 69():320-6. PubMed ID: 25748623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence of Hepatitis E Virus in Autoimmune Hepatitis Patients in the Netherlands.
    van Gerven NM; van der Eijk AA; Pas SD; Zaaijer HL; de Boer YS; Witte BI; van Nieuwkerk CM; Mulder CJ; Bouma G; de Man RA;
    J Gastrointestin Liver Dis; 2016 Mar; 25(1):9-13. PubMed ID: 27014749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis E virus infection in Brazil: results of laboratory-based surveillance from 1998 to 2013.
    Passos-Castilho AM; de Sena A; Reinaldo MR; Granato CF
    Rev Soc Bras Med Trop; 2015; 48(4):468-70. PubMed ID: 26132499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis E Virus Seroprevalence and Correlates of Anti-HEV IgG Antibodies in the Rakai District, Uganda.
    Boon D; Redd AD; Laeyendecker O; Engle RE; Nguyen H; Ocama P; Boaz I; Ndyanabo A; Kiggundu V; Reynolds SJ; Gray RH; Wawer MJ; Purcell RH; Kirk GD; Quinn TC; Stabinski L;
    J Infect Dis; 2018 Feb; 217(5):785-789. PubMed ID: 29186448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of anti-hepatitis E virus immunoglobulin G in HIV-infected individuals over three decades.
    Harritshøj LH; Kirkegaard-Klitbo DM; Mejer N; Panum I; Midgley SE; Ullum H; Benfield T
    Int J Infect Dis; 2019 Jul; 84():67-72. PubMed ID: 31063824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.